CHANGE IN CONTROL RETENTION AGREEMENTChange in Control Retention Agreement • May 11th, 2021 • Organogenesis Holdings Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control Retention Agreement (this “Agreement”) is entered into as of May 10, 2021, by and between Organogenesis Holdings Inc., a Delaware corporation with its principal offices located at 85 Dan Road, Canton, Massachusetts 02021 (together with its successors and assigns, the “Company”), and Gary S. Gillheeney, Sr. (the “Executive”).
CHANGE IN CONTROL RETENTION AGREEMENTChange in Control Retention Agreement • May 11th, 2021 • Organogenesis Holdings Inc. • Pharmaceutical preparations • Massachusetts
This Change in Control Retention Agreement (this “Agreement”) is entered into as of [DATE], by and between Organogenesis Holdings Inc., a Delaware corporation with its principal offices located at 85 Dan Road, Canton, Massachusetts 02021 (together with its successors and assigns, the “Company”), and [name of board member] (the “Director”).
